CPBI vs CGTX
Comparison between Central Plains Bancshares Inc (CPBI, Company) and Cognition Therapeutics Inc (CGTX, Company).
CPBI is from the Financial Services sector, while CGTX is from the Healthcare sector.
CPBI vs CGTX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CPBI vs CGTX - Historical Returns
Returns include dividend reinvestment.
CPBI vs CGTX - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | CPBI | CGTX |
|---|---|---|
| 2026 | +18.09% | -34.68% |
| 2025 | +14.17% | +86.70% |
| 2024 | +41.67% | -63.85% |
| 2023 | +12.09% | -9.76% |
| 2022 | N/A | -66.40% |
| 2021 | N/A | -50.51% |
CPBI vs CGTX Drawdown Comparison
The maximum drawdown for CPBI was -8.44%, occurring on Apr 10, 2025. Recovery took 124 trading sessions.
The maximum drawdown for CGTX was -98.16%, occurring on May 30, 2025. This drawdown has not yet recovered.
The current CPBI drawdown is -1.08%. The current CGTX drawdown is -92.60%.
| Rank | CPBI | CGTX |
|---|---|---|
| #1 | -8.44% Dec 20, 2024 - Jun 24, 2025 | -98.16% Nov 9, 2021 - May 30, 2025 |
| #2 | -7.96% Jan 9, 2024 - Jul 23, 2024 | -6.81% Oct 8, 2021 - Nov 9, 2021 |
| #3 | -5.39% Jul 31, 2024 - Aug 8, 2024 | N/A |
| #4 | -4.95% Oct 7, 2025 - Dec 12, 2025 | N/A |
| #5 | -4.15% Mar 11, 2026 - May 21, 2026 | N/A |
| #6 | -4.12% Sep 4, 2025 - Sep 29, 2025 | N/A |
| #7 | -4.05% Dec 11, 2024 - Dec 20, 2024 | N/A |
| #8 | -4.00% Dec 4, 2023 - Dec 26, 2023 | N/A |
| #9 | -3.76% Feb 25, 2026 - Mar 11, 2026 | N/A |
| #10 | -3.72% Jan 22, 2026 - Jan 26, 2026 | N/A |
| #11 | -3.65% Nov 3, 2023 - Nov 13, 2023 | N/A |
| #12 | -3.62% Nov 8, 2024 - Dec 11, 2024 | N/A |
| #13 | -3.13% Oct 18, 2024 - Nov 1, 2024 | N/A |
| #14 | -2.88% Oct 11, 2024 - Oct 16, 2024 | N/A |
| #15 | -2.87% Aug 26, 2024 - Sep 19, 2024 | N/A |
Correlation
Correlation between CPBI and CGTX is -0.31 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks